UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000040984 |
|---|---|
| Receipt number | R000046798 |
| Scientific Title | Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor |
| Date of disclosure of the study information | 2020/07/03 |
| Last modified on | 2021/07/03 09:03:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor
Acronym
Questionnaire survey about information and support for thoracic cancer patients
Scientific Title
Questionnaire survey about information and support for patients with lung cancer, mesothelioma or thymic tumor
Scientific Title:Acronym
Questionnaire survey about information and support for thoracic cancer patients
Region
| Japan |
Condition
Condition
lung cancer, mesothelioma and thymic tumor
Classification by specialty
| Pneumology | Hematology and clinical oncology | Surgery in general |
| Chest surgery | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to investigate the degree of satisfaction with medical information obtained by patients.
We conduct a questionnaire survey of patients with lung cancer, mesothelioma, and thymic tumor. The questionnaire contains questions from researchers, EORTC QLQ C30 and INFO25.
Basic objectives2
Others
Basic objectives -Others
The purpose is to improve the content and quality of medical information to be provided.
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Compare the degree of satisfaction with the medical information obtained between the purchase group and the non-purchase group of [Lung cancer guidebook for patients].
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Patients diagnosed with lung cancer, malignant pleural mesothelioma, or thymic tumor (histopathological diagnosis is not essential)
2) Patients consent to this study registration
Key exclusion criteria
Not applicable.
Target sample size
200
Research contact person
Name of lead principal investigator
| 1st name | Sawa |
| Middle name | |
| Last name | Toshiyuki |
Organization
Gifu municipal Hospital
Division name
Cancer center
Zip code
500-8513
Address
7-1, Kashima-cho,Gifu city, Gifu
TEL
(058)251-1101
sawatoshiyuki@yahoo.co.jp
Public contact
Name of contact person
| 1st name | Takayuki |
| Middle name | |
| Last name | Takahama |
Organization
Kindai University Nara Hospital
Division name
Department of medical oncology
Zip code
6300293
Address
1248-1, Otoda, Ikoma city, Nara
TEL
0743-77-0880
Homepage URL
takahama_t@med.kindai.ac.jp
Sponsor or person
Institute
The Japan lung cancer society
Institute
Department
Personal name
Funding Source
Organization
The Japan lung cancer society
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kindai University Nara Hospital
Address
1248-1, Otoda, Ikoma city, Nara
Tel
0743-77-0880
n-rinri@med.kindai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 07 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
332
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2020 | Year | 06 | Month | 29 | Day |
Date of IRB
| 2020 | Year | 06 | Month | 30 | Day |
Anticipated trial start date
| 2020 | Year | 07 | Month | 03 | Day |
Last follow-up date
| 2022 | Year | 07 | Month | 02 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Request QOL survey and input from researcher's questionnaire.
Management information
Registered date
| 2020 | Year | 07 | Month | 02 | Day |
Last modified on
| 2021 | Year | 07 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046798
